Chemoinformaics analysis of N-[2-(4-methoxyphenyl)ethyl]benzamide
| Molecular Weight | 255.317 | nRot | 5 |
| Heavy Atom Molecular Weight | 238.181 | nRig | 13 |
| Exact Molecular Weight | 255.126 | nRing | 2 |
| Solubility: LogS | -3.394 | nHRing | 0 |
| Solubility: LogP | 2.741 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 40.7595 |
| nHD | 1 | BPOL | 20.2285 |
| QED | 0.892 |
| Synth | 1.334 |
| Natural Product Likeliness | -0.784 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.18 |
| Pgp-sub | 0.034 |
| HIA | 0.006 |
| CACO-2 | -4.631 |
| MDCK | 0.0000161 |
| BBB | 0.401 |
| PPB | 0.956561 |
| VDSS | 0.975 |
| FU | 0.0296644 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.889 |
| CYP2c19-inh | 0.963 |
| CYP2c19-sub | 0.357 |
| CYP2c9-inh | 0.896 |
| CYP2c9-sub | 0.898 |
| CYP2d6-inh | 0.927 |
| CYP2d6-sub | 0.884 |
| CYP3a4-inh | 0.699 |
| CYP3a4-sub | 0.433 |
| CL | 8.44 |
| T12 | 0.622 |
| hERG | 0.592 |
| Ames | 0.337 |
| ROA | 0.028 |
| SkinSen | 0.55 |
| Carcinogencity | 0.214 |
| EI | 0.191 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.675865 |